Published on 24/04/2020 6:37 | Source: ANI
For more videos Subscribe now! https://bit.ly/2YrTXdM and stay connected with us
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel https://t.me/InvestmentGuruIndia
Download Telegram App before Joining the Channel
Ahmedabad (Gujarat): Senior vice president of Indian Drug Manufacturers’ Association (IDMA), Viranchi Shah said that India’s current production capacity of Hydroxychloroquine is 35-40 crore tablets a month. While speaking to ANI, he said, “India holds almost 70% global capacity of manufacturing Hydroxychloroquine (HCQ). Our current production capacity of Hydroxychloroquine is 35-40 crore tablets a month. This is 10 times more than our requirement. There is no shortage of HCQ in India and we have sufficient amount of it to supply outside.”
Tech Mahindra Q2 net profit down 31.16% at Rs 961.50 cr
Aarti Drugs Ltd Q2 net profit zooms 126.56% at Rs 69.78 cr
Some tentativeness around 12000, but odds in favor of bulls By Sameet Chavan, Angel Broking
Railways receives 2.4 cr applications for 1.4L posts
Sell Copper In The Range OF 530-530.50 SL Above 533 TGT 526/524 - Axis Securities
